Pharming Group Nv Stock Market Value
| PHGUF Stock | USD 0.90 0.11 13.92% |
| Symbol | Pharming |
Pharming Group 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharming Group's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharming Group.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in Pharming Group on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Pharming Group NV or generate 0.0% return on investment in Pharming Group over 90 days. Pharming Group is related to or competes with IGG, and Sino Biopharmaceutica. Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision... More
Pharming Group Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharming Group's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharming Group NV upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1321 | |||
| Maximum Drawdown | 24.13 | |||
| Value At Risk | (3.06) | |||
| Potential Upside | 5.68 |
Pharming Group Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharming Group's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharming Group's standard deviation. In reality, there are many statistical measures that can use Pharming Group historical prices to predict the future Pharming Group's volatility.| Risk Adjusted Performance | 0.0857 | |||
| Jensen Alpha | 0.2788 | |||
| Total Risk Alpha | 0.8659 | |||
| Treynor Ratio | (1.95) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pharming Group's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pharming Group NV Backtested Returns
Pharming Group appears to be extremely dangerous, given 3 months investment horizon. Pharming Group NV maintains Sharpe Ratio (i.e., Efficiency) of 0.0964, which implies the firm had a 0.0964 % return per unit of risk over the last 3 months. We have found twenty-one technical indicators for Pharming Group NV, which you can use to evaluate the volatility of the company. Please evaluate Pharming Group's Variance of 11.25, risk adjusted performance of 0.0857, and Coefficient Of Variation of 1079.16 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Pharming Group holds a performance score of 7. The company holds a Beta of -0.15, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Pharming Group are expected to decrease at a much lower rate. During the bear market, Pharming Group is likely to outperform the market. Please check Pharming Group's variance and the relationship between the treynor ratio and price action indicator , to make a quick decision on whether Pharming Group's historical price patterns will revert.
Auto-correlation | -0.52 |
Good reverse predictability
Pharming Group NV has good reverse predictability. Overlapping area represents the amount of predictability between Pharming Group time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharming Group NV price movement. The serial correlation of -0.52 indicates that about 52.0% of current Pharming Group price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.52 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Pharming Group NV lagged returns against current returns
Autocorrelation, which is Pharming Group pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pharming Group's pink sheet expected returns. We can calculate the autocorrelation of Pharming Group returns to help us make a trade decision. For example, suppose you find that Pharming Group has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pharming Group regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pharming Group pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pharming Group pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pharming Group pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Pharming Group Lagged Returns
When evaluating Pharming Group's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pharming Group pink sheet have on its future price. Pharming Group autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pharming Group autocorrelation shows the relationship between Pharming Group pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Pharming Group NV.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Pharming Pink Sheet
When determining whether Pharming Group NV is a strong investment it is important to analyze Pharming Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pharming Group's future performance. For an informed investment choice regarding Pharming Pink Sheet, refer to the following important reports:Check out Pharming Group Correlation, Pharming Group Volatility and Pharming Group Alpha and Beta module to complement your research on Pharming Group. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Pharming Group technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.